<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr2">
 <label>2</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Yao</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ye</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cui</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Huang</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Niu</surname>
    <given-names>P</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2).</article-title>
  <source>Clin Infect Dis</source>
  <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">. </span>
  <year>2020</year>
  <month>3</month>
  <day>9</day>:
  <fpage>ciaa237</fpage>. doi: 
  <pub-id pub-id-type="doi">10.1093/cid/ciaa237</pub-id>.
 </mixed-citation>
</ref>
